Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model

Cancer Biology and Therapy

Volumn 7, Issue 1, 2008, Pages 76-80

  Song, Emma Y ^a,b   Qu, Chang F ^a,c   Rizvi, Syed M A ^a   Raja, Chand ^a   Beretov, Julia ^a   Morgenstern, Alfred ^c   Apostolidis, Christos ^c   Bruchertseifer, Frank ^c   Perkins, Alan ^d   Allen, Barry J ^a,b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c JOINT RESEARCH CENTRE   (Italy)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

A particles; C595; MUC1; Ovarian cancer; Radioimmunotherapy

Indexed keywords

ANTIBODY CONJUGATE; BISMUTH 213; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C595; MONOCLONAL ANTIBODY MUC1; MUCIN 1; PENTETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DISEASE CONTROL; DRUG DISTRIBUTION; IMMUNOASSAY; MOUSE; NONHUMAN; OVARY CANCER; PROTEIN EXPRESSION;

EID: 42549102773     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.1.5132     Document Type: Article

References (17)